STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
about
Selective regulatory function of Socs3 in the formation of IL-17-secreting T cellsThe emerging roles of GPRC5A in diseasesThe role of suppressors of cytokine signalling in human neoplasmsProtein phosphatase 2A (PP2A) regulates interleukin-4-mediated STAT6 signalingSTAT3 as a therapeutic target in head and neck cancerTyrosine-phosphorylated SOCS3 interacts with the Nck and Crk-L adapter proteins and regulates Nck activation.Transcriptional activation of the suppressor of cytokine signaling-3 (SOCS-3) gene via STAT3 is increased in F9 REX1 (ZFP-42) knockout teratocarcinoma stem cells relative to wild-type cellsImmunohistochemical analysis of IL-6, IL-8/CXCR2 axis, Tyr p-STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: correlation between microvascular characteristics and prognostic significance.Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activationClinical significance of mucosal suppressors of cytokine signaling 3 expression in ulcerative colitis.Silencing SOCS3 could inhibit TNF-α induced apoptosis in 3T3-L1 and mouse preadipocytes.Loss of expression and function of SOCS3 is an early event in HNSCC: altered subcellular localization as a possible mechanism involved in proliferation, migration and invasionInterleukin-6 and new strategies for the treatment of cancer, hyperproliferative diseases and paraneoplastic syndromes.t(8;9)(p22;p24)/PCM1-JAK2 activates SOCS2 and SOCS3 via STAT5.Molecular cytogenetic characterization of Sézary syndrome.Brassinin inhibits STAT3 signaling pathway through modulation of PIAS-3 and SOCS-3 expression and sensitizes human lung cancer xenograft in nude mice to paclitaxelInhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5 signalling.Expression of interleukin-8 receptor CXCR2 and suppressor of cytokine signaling-3 in astrocytic tumors.Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma.Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas.SOCS3 is an endogenous inhibitor of pathologic angiogenesis.Suppressor of cytokine signalling gene expression is elevated in breast carcinomaStaphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphomaEndogenous transmembrane protein UT2 inhibits pSTAT3 and suppresses hematological malignancySOCS regulation of the JAK/STAT signalling pathway.Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytesLack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma.Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma.Increased Twist expression in advanced stage of mycosis fungoides and Sézary syndromeRegulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome.The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma.Cutaneous T-cell lymphomas: a review of new discoveries and treatments.An insight into JAK-STAT signalling in dermatology.Suppressor of cytokine signaling 3 expression in anaplastic large cell lymphoma.IL-6/STAT3 Plays a Regulatory Role in the Interaction Between Pancreatic Stellate Cells and Cancer Cells.Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphomaConstitutive activation of STAT3 in Sézary syndrome is independent of SHP-1.Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha.STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides.STAT3 signaling pathway is involved in decitabine induced biological phenotype regulation of acute myeloid leukemia cells
P2860
Q24547568-56B5A52A-215D-42C0-8642-BE524F945C07Q27020926-F4592CD2-5C65-444E-9F14-67C7E79BDC5FQ27026783-AEBFE9FD-D611-4B9F-8714-5BBA15AA6AD0Q28214491-6A229736-E68D-488E-8C6E-E545A7E34186Q28299368-64A829DB-1823-443E-9CC1-5160F373D265Q30164048-D34972C7-55B8-4DCD-BC03-02A129C77894Q30176405-D464FC46-FC08-4D07-BF43-0BC60BE6B3CAQ33634642-21069C46-C07A-41F4-ADA7-E2AF414C7072Q33737707-CD58DA9B-C899-4D7C-AB80-9733CF247404Q34224726-1636F124-7914-4A94-AFC3-34810E23236BQ34310068-85214B60-3917-4F97-B8A5-A571B821109AQ34428326-B7E2BBA4-B5C5-4816-A244-3A23E38F8889Q34440657-BC1B3E80-DCCD-46E8-B785-9BEF57778FDBQ34570939-9FB67EE8-0F3C-4001-993F-305C0F13DADBQ35056476-B21254C8-437F-4688-8EBA-5936CEC5451CQ35742549-04516AA7-57FC-493D-97C2-DC238E2D52F4Q35893359-765D8AB7-2A42-41E0-998F-4E89870FBB14Q35973308-40941565-2611-463E-9F79-5357EF308BE7Q36020985-5846BFF1-C167-4F79-BFC6-30F17B2C4C11Q36048656-3F45E3CB-6DCC-4339-B612-9BFC641CC24CQ36305360-E8F454ED-E913-4E49-9D1D-6E168ADAD237Q36671376-70ADDC31-5DF0-42EB-BF19-3207B0DF46F4Q36675064-9FC96B1F-8E44-4579-B1F9-BBF3EADA66AEQ36737884-AAA68415-DA70-472C-86EB-7959704B151BQ37003892-C93FA26E-AD3C-49F3-8381-5754FF444E63Q37052050-E6701021-35C9-459C-B44F-341D9F98292AQ37052602-1FD1C3E1-3D8A-47D2-8759-82C3E6B66AD3Q37139517-5E9455F2-CA1D-4863-BC27-F9AF922FB033Q37230256-36C76F94-E766-41F7-B915-B3ADF58A741AQ37929548-31C4321B-7389-48C1-8078-53336016FA84Q37975058-07EFAB56-D4A9-4E54-A42E-355939A47E86Q37981969-DEA7BF12-808A-4D48-BD98-057B89CC070EQ38211580-F667C8A1-DD8F-4F16-B153-69222D32AC2DQ38336235-5BF34933-9D9A-4027-AC5C-F36B5D949D5DQ38806134-63897B7A-E489-45E7-92AD-ED891845E6E8Q38846167-2E47E1D4-BD11-4F06-ACD2-C98C07DB3031Q39494833-7A29B028-4630-4D71-B2AD-0C225CA39C10Q40477164-841DF775-243C-40B0-80F4-8FE670A93992Q40802496-03EA2E31-6CCA-48F7-B472-5A504E5872C6Q42250309-5CC47461-B72F-4E7E-BE56-AD2A2BEFB34C
P2860
STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
@ast
STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
@en
type
label
STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
@ast
STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
@en
prefLabel
STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
@ast
STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
@en
P2093
P356
P1433
P1476
STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
@en
P2093
G Mikkelsen
P304
P356
10.1182/BLOOD.V97.4.1056
P407
P577
2001-02-01T00:00:00Z